Literature DB >> 7621443

Cytokine regulation of HIV-1 LTR transactivation in human hepatocellular carcinoma cell lines.

M L Hsu1, S W Chen, K H Lin, S K Liao, K S Chang.   

Abstract

Human hepatocellular carcinoma (HCC) cell lines, HEP-G2, J5, and SK-HEP-1, which differ in their differentiation status, were compared for their trans-activating activities after treatment with cytokines or 12-O-tetradecanoylphorbol-13-acetate (TPA). These cells were transfected with a long terminal repeat (LTR) which was derived from human immunodeficiency virus type 1 (HIV-1) and ligated to chloramphenicol acetyl transferase (CAT) gene. After treatment with interleukin-1 alpha (IL-1 alpha), interleukin-6 (IL-6), interferon-gamma (IFN-gamma), or TPA, they exhibited various degrees of enhancement of transactivation. The well differentiated HEP-G2 cells exhibited the highest degree of enhancement with these agents, while the poorly differentiated SK-HEP-1 cells showed no enhancement with cytokines and slight enhancement with TPA. The J5 cells, which were intermediate in their status of differentiation, showed a moderate degree of enhancement with cytokines and TPA. These results suggest that HCC cells at different stages of differentiation may produce different levels of cellular transacting factors activated by each of these agents. To map the cytokine response elements (CREs) in the HIV-1-LTR, HEP-G2 cells were transfected with nested series of 5' deletion mutants of HIV-1-LTR and treated with each of these cytokines. It was found that not only the degrees but also the patterns of enhancement varied depending upon the presence of positive or negative regulatory sequences in HIV-1-LTR, and that the NF-kappa B sequence played an important role, either by itself or in conjunction with the 5'-proximal response elements (REs) to interact with cellular trans-activating factors elicited by the cascade of transduction responses to cytokines. Despite the presence of promoters including kappa B and IFN-gamma RE as well as IL-6RE sequence in HIV-1-LTR-transfected cells, the poorly differentiated SK-HEP-1 cells showed no enhancement of transactivation by these cytokines, suggesting the lack of receptors or activity of some signal transduction factors which are present in well differentiated HEP-G2 and moderately differentiated J5 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621443     DOI: 10.1016/0304-3835(95)03820-m

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.

Authors:  Hung-Hua Liang; Po-Li Wei; Chin-Sheng Hung; Chun-Te Wu; Weu Wang; Ming-Te Huang; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-06-13

2.  Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma.

Authors:  Po-Li Wei; Chien-Yu Huang; Cheng-Jeng Tai; Uyanga Batzorig; Wan-Li Cheng; Ming-Te Hunag; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2015-12-30

3.  Low-level HIV infection of hepatocytes.

Authors:  Ling Kong; Walter Cardona Maya; Maria E Moreno-Fernandez; Gang Ma; Mohamed T Shata; Kenneth E Sherman; Claire Chougnet; Jason T Blackard
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

4.  A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells.

Authors:  Chun-Te Ho; Yu-Jia Chang; Li-Xi Yang; Po-Li Wei; Tsan-Zon Liu; Jun-Jen Liu
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

5.  Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.

Authors:  Ruo-Chiau Wang; Chien-Yu Huang; Tai-Long Pan; Wei-Yu Chen; Chun-Te Ho; Tsan-Zon Liu; Yu-Jia Chang
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

6.  IGFBP2 plays an important role in heat shock protein 27-mediated cancer progression and metastasis.

Authors:  Chin-Sheng Hung; Chien-Yu Huang; Chia-Hwa Lee; Wei-Yu Chen; Ming-Te Huang; Po-Li Wei; Yu-Jia Chang
Journal:  Oncotarget       Date:  2017-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.